Five-Year clinical trial on Atropine for the Treatment of Myopia 2
Purpose: To compare the safety and efficacy of different concentrations of atropine eyedrops in controlling myopia progression over 5 years. Design: Randomized, double-masked clinical trial. Participants: A total of 400 children originally randomized to receive atropine 0.5%, 0.1%, or 0.01% once dai...
Saved in:
Main Authors: | Chia, Audrey, Lu, Qing-Shu, Tan, Donald |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/88006 http://hdl.handle.net/10220/46880 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study
by: Chia, A., et al.
Published: (2016) -
Update in myopia and treatment strategy of atropine use in myopia control
by: Wu, P.-C, et al.
Published: (2020) -
Muscarinic mechanisms in a mouse model of myopia
by: VELUCHAMY AMUTHA BARATHI
Published: (2010) -
Topical atropine for childhood myopia control: the atropine treatment long-term assessment study
by: Li, Yong, et al.
Published: (2024) -
Effect of muscarinic agents on sclera fibroblast and their role in myopia
by: CHA YEON LANG
Published: (2010)